Clinical Trials

Target accrual: Approach 100 patients with a clincially indicated endoscopic ultrasound procedure with ideally at least 70 subjects agreeing to consent at the Mayo Clinic Rochester location.

Subject population (children, adults, groups):  Patients (>18 years of age) with a solid pancreas tumor requiring a clinical endoscopic ultrasound for diagnostic and staging purposes will be approached and enrolled. The study objective is to complete all aspects of the study for 70 patients, and therefore will require approaching approximately100 patients for this proof of principle study. The corresponding Mayo Clinic electronic medical record for up to 5 years following enrollment is needed for complete evaluation.

Describe subject eligibility criteria, including the population(s) from which biospecimens/information will be obtained:  All patients with a clinically indicated endoscopic ultrasound procedure with an indication for a solid pancreas tumor evaluation for diagnosis and staging, who are over 18 years of age, not pregnant and freely of their own will, able to complete a written informed consent.

Describe provisions for inclusion of minorities: As per above all individuals are eligible. This study will not target a particular population or demographic or ethnicity.